Literature DB >> 16186423

Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia.

Vasken Dilsizian1, Timothy M Bateman, Steven R Bergmann, Roger Des Prez, Martin Y Magram, Anne E Goodbody, John W Babich, James E Udelson.   

Abstract

BACKGROUND: After myocardial ischemia, prolonged suppression of fatty acid metabolism may persist despite restoration of blood flow, which is called metabolic stunning. We hypothesized that a branched-chain fatty acid, beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid (BMIPP), might identify the presence of myocardial ischemia late after demand ischemia at rest up to 30 hours later. METHODS AND
RESULTS: In 32 patients with exercise-induced ischemia on thallium SPECT, BMIPP was injected at rest within 30 hours of ischemia. SPECT images were acquired beginning 10 minutes after injection (early) and again 30 minutes after injection (delayed). Thallium and BMIPP SPECT data were read separately by 3 observers blinded to other imaging and clinical data. Agreement between BMIPP and thallium data for the presence of an abnormality on the patient level was 91% (95% CI, 75 to 98) for the early BMIPP data and 94% (95% CI, 79 to 99) for the delayed BMIPP data. Agreement between delayed BMIPP and thallium was 95% among 21 patients studied on the same day, a mean of 6.2+/-1.4 hours after exercise-induced ischemia, and 91% among the 11 patients studied on the next calendar day, a mean of 24.9+/-2.6 hours after ischemia (P=NS). The magnitude of resting BMIPP metabolic defect by semiquantitative visual analysis was correlated to the magnitude of exercise-induced thallium perfusion defect (r=0.6, P<0.001 for early BMIPP; r=0.5, P=0.005 for delayed BMIPP).
CONCLUSIONS: Metabolic imaging with BMIPP identifies patients with recent exercise-induced myocardial ischemia. These findings support the concept that BMIPP imaging can successfully demonstrate the metabolic imprint of a stress-induced ischemic episode, also known as ischemic memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186423     DOI: 10.1161/CIRCULATIONAHA.104.530428

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

Review 2.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 3.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

Review 4.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 5.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

6.  Molecular imaging: Measuring myocardial fatty acid metabolism with BMIPP SPECT.

Authors:  Raphaël Duivenvoorden; Zahi A Fayad
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 7.  Diagnostic and prognostic value of BMIPP imaging.

Authors:  Taishiro Chikamori; Akira Yamashina; Satoshi Hida; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 8.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

Review 9.  Exploring the Pathophysiology of Takotsubo Cardiomyopathy.

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 10.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.